Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Francesco Gaudio

ResearcherPublications, citations & collaboration network

Francesco Gaudio is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 101 works, 1,191 citations, an h-index of 19 and an i10-index of 36.

101
Works
1,191
Citations
19
h-index
36
i10-index

How has Francesco Gaudio's publication output changed over time?

ScholarIQpublication output · 2002–2024

Output grew0% over the shown period — from 1 works in 2002 to 1 in 2024.

1
1
1
3
2
1
1
1
20022006201020112014201820202024

What are the most-cited papers on Francesco Gaudio?

ScholarIQmost cited works
BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients
Giuseppe Visani, Lara Malerba, Pietro Maria Stefani, Saveria Capria, Piero Galieni, Francesco Gaudio, Giorgina Specchia, Giovanna Meloni, Filíppo Gherlinzoni, Claudio Giardini, Sadia Falcioni, Francesca Cuberli, Marco Gobbi, Barbara Sarina, Armando Santoro, Felicetto Ferrara, Marco Rocchi, Enrique M. Ocio, Marı́a Dolores Caballero, Alessandro Isidori
Blood. 2011138 CitationsOPEN ACCESS
Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation
Vincenzo Pavone, Francesco Gaudio, Giuseppe Console, Umberto Vitolo, Pasquale Iacopino, Attilio Guarini, Vincenzo Liso, Tommasina Perrone, Arcangelo Liso
S183182149. 2006115 Citations
Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma
Vincenzo Pavone, Francesco Gaudio, Attilio Guarini, Tommasina Perrone, Alessandra Zonno, Paola Curci, Vincenzo Liso
S183182149. 200280 Citations
High Ki67 Index and Bulky Disease Remain Significant Adverse Prognostic Factors in Patients with Diffuse Large B Cell Lymphoma before and after the Introduction of Rituximab
Francesco Gaudio, Annamaria Giordano, Tommasina Perrone, Domenico Pastore, Paola Curci, Mario Delia, Anna Napoli, Clara De Risi, Alessandro Spina, R Ricco, Vincenzo Liso, Giorgina Specchia
S182948766. 201165 Citations
Microvascular density, CD68 and tryptase expression in human Diffuse Large B-Cell Lymphoma
Christian Marinaccio, Giuseppe Ingravallo, Francesco Gaudio, Tommasina Perrone, Beatrice Nico, Eugenio Maoirano, Giorgina Specchia, Doménico Ribatti
Leukemia Research. 201456 Citations

Related on ScholarIQ

Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari
Institution
BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients
Paper
Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation
Paper
Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma
Paper
High Ki67 Index and Bulky Disease Remain Significant Adverse Prognostic Factors in Patients with Diffuse Large B Cell Lymphoma before and after the Introduction of Rituximab
Paper
Microvascular density, CD68 and tryptase expression in human Diffuse Large B-Cell Lymphoma
Paper
470M+ articles · free account